United States Low Molecular Weight Heparin Market Report 2017

2017-07-17 / 3800.00 / Pharma & Healthcare / 113 Pages

Description

In this report, the United States Low Molecular Weight Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Low Molecular Weight Heparin in these regions, from 2012 to 2022 (forecast).

United States Low Molecular Weight Heparin market competition by top manufacturers/players, with Low Molecular Weight Heparin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi
Bharat Biotech
Hepalink
Changshan Biochemical
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen
King-friend Biochemical Pharmaceutical
Dongcheng Biochemicals
Jiulong Biochemicals
Xinbai Pharmaceuticals
Deebio

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Dalteparin
Enoxaparin
Tinzaparin
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Low Molecular Weight Heparin for each application, including
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

United States Low Molecular Weight Heparin Market Report 2017
1 Low Molecular Weight Heparin Overview
1.1 Product Overview and Scope of Low Molecular Weight Heparin
1.2 Classification of Low Molecular Weight Heparin by Product Category
1.2.1 United States Low Molecular Weight Heparin Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Low Molecular Weight Heparin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Dalteparin
1.2.4 Enoxaparin
1.2.5 Tinzaparin
1.2.6 Others
1.3 United States Low Molecular Weight Heparin Market by Application/End Users
1.3.1 United States Low Molecular Weight Heparin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.4 United States Low Molecular Weight Heparin Market by Region
1.4.1 United States Low Molecular Weight Heparin Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.4.3 Southwest Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.4.5 New England Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.4.6 The South Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.4.7 The Midwest Low Molecular Weight Heparin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Low Molecular Weight Heparin (2012-2022)
1.5.1 United States Low Molecular Weight Heparin Sales and Growth Rate (2012-2022)
1.5.2 United States Low Molecular Weight Heparin Revenue and Growth Rate (2012-2022)

2 United States Low Molecular Weight Heparin Market Competition by Players/Suppliers
2.1 United States Low Molecular Weight Heparin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Low Molecular Weight Heparin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Low Molecular Weight Heparin Average Price by Players/Suppliers (2012-2017)
2.4 United States Low Molecular Weight Heparin Market Competitive Situation and Trends
2.4.1 United States Low Molecular Weight Heparin Market Concentration Rate
2.4.2 United States Low Molecular Weight Heparin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Low Molecular Weight Heparin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Low Molecular Weight Heparin Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Low Molecular Weight Heparin Sales and Market Share by Region (2012-2017)
3.2 United States Low Molecular Weight Heparin Revenue and Market Share by Region (2012-2017)
3.3 United States Low Molecular Weight Heparin Price by Region (2012-2017)

4 United States Low Molecular Weight Heparin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Low Molecular Weight Heparin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Low Molecular Weight Heparin Revenue and Market Share by Type (2012-2017)
4.3 United States Low Molecular Weight Heparin Price by Type (2012-2017)
4.4 United States Low Molecular Weight Heparin Sales Growth Rate by Type (2012-2017)

5 United States Low Molecular Weight Heparin Sales (Volume) by Application (2012-2017)
5.1 United States Low Molecular Weight Heparin Sales and Market Share by Application (2012-2017)
5.2 United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Low Molecular Weight Heparin Players/Suppliers Profiles and Sales Data
6.1 Sanofi
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bharat Biotech
6.2.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bharat Biotech Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Hepalink
6.3.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Hepalink Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Changshan Biochemical
6.4.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Changshan Biochemical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Qianhong Bio-pharma
6.5.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Opocrin
6.6.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Opocrin Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Aspen
6.8.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Aspen Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 King-friend Biochemical Pharmaceutical
6.9.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Dongcheng Biochemicals
6.10.2 Low Molecular Weight Heparin Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Dongcheng Biochemicals Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Jiulong Biochemicals
6.12 Xinbai Pharmaceuticals
6.13 Deebio

7 Low Molecular Weight Heparin Manufacturing Cost Analysis
7.1 Low Molecular Weight Heparin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Low Molecular Weight Heparin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Low Molecular Weight Heparin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Low Molecular Weight Heparin Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Low Molecular Weight Heparin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Low Molecular Weight Heparin Sales Volume Forecast by Type (2017-2022)
11.3 United States Low Molecular Weight Heparin Sales Volume Forecast by Application (2017-2022)
11.4 United States Low Molecular Weight Heparin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Product Picture of Low Molecular Weight Heparin
Figure United States Low Molecular Weight Heparin Market Size (K MT) by Type (2012-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Market Share by Type (Product Category) in 2016
Figure Dalteparin Product Picture
Figure Enoxaparin Product Picture
Figure Tinzaparin Product Picture
Figure Others Product Picture
Figure United States Low Molecular Weight Heparin Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Low Molecular Weight Heparin by Application in 2016
Figure Treatment of Venous Thromboembolism Examples
Table Key Downstream Customer in Treatment of Venous Thromboembolism
Figure Complications of Pregnancy Examples
Table Key Downstream Customer in Complications of Pregnancy
Figure Cardioversion of Atrial Fibrillation/Flutter Examples
Table Key Downstream Customer in Cardioversion of Atrial Fibrillation/Flutter
Figure United States Low Molecular Weight Heparin Market Size (Million USD) by Region (2012-2022)
Figure The West Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Sales (K MT) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low Molecular Weight Heparin Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low Molecular Weight Heparin Sales Share by Players/Suppliers
Figure 2017 United States Low Molecular Weight Heparin Sales Share by Players/Suppliers
Figure United States Low Molecular Weight Heparin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Low Molecular Weight Heparin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers
Figure 2017 United States Low Molecular Weight Heparin Revenue Share by Players/Suppliers
Table United States Market Low Molecular Weight Heparin Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Low Molecular Weight Heparin Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Low Molecular Weight Heparin Market Share of Top 3 Players/Suppliers
Figure United States Low Molecular Weight Heparin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Low Molecular Weight Heparin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Low Molecular Weight Heparin Product Category
Table United States Low Molecular Weight Heparin Sales (K MT) by Region (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Region in 2016
Table United States Low Molecular Weight Heparin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Revenue Market Share by Region (2012-2017)
Figure United States Low Molecular Weight Heparin Revenue Market Share by Region in 2016
Table United States Low Molecular Weight Heparin Price (USD/MT) by Region (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) by Type (2012-2017)
Table United States Low Molecular Weight Heparin Sales Share by Type (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Share by Type (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Type in 2016
Table United States Low Molecular Weight Heparin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Low Molecular Weight Heparin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Low Molecular Weight Heparin by Type (2012-2017)
Figure Revenue Market Share of Low Molecular Weight Heparin by Type in 2016
Table United States Low Molecular Weight Heparin Price (USD/MT) by Types (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Type (2012-2017)
Table United States Low Molecular Weight Heparin Sales (K MT) by Application (2012-2017)
Table United States Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Market Share by Application in 2016
Table United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Sanofi Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Sanofi Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bharat Biotech Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Bharat Biotech Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Bharat Biotech Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Hepalink Basic Information List
Table Hepalink Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hepalink Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Hepalink Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Hepalink Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Changshan Biochemical Basic Information List
Table Changshan Biochemical Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Changshan Biochemical Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Changshan Biochemical Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Changshan Biochemical Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Qianhong Bio-pharma Basic Information List
Table Qianhong Bio-pharma Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Qianhong Bio-pharma Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Qianhong Bio-pharma Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Qianhong Bio-pharma Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Opocrin Basic Information List
Table Opocrin Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Opocrin Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Pfizer Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Aspen Basic Information List
Table Aspen Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Aspen Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Aspen Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table King-friend Biochemical Pharmaceutical Basic Information List
Table King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Dongcheng Biochemicals Basic Information List
Table Dongcheng Biochemicals Low Molecular Weight Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dongcheng Biochemicals Low Molecular Weight Heparin Sales Growth Rate (2012-2017)
Figure Dongcheng Biochemicals Low Molecular Weight Heparin Sales Market Share in United States (2012-2017)
Figure Dongcheng Biochemicals Low Molecular Weight Heparin Revenue Market Share in United States (2012-2017)
Table Jiulong Biochemicals Basic Information List
Table Xinbai Pharmaceuticals Basic Information List
Table Deebio Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Low Molecular Weight Heparin
Figure Manufacturing Process Analysis of Low Molecular Weight Heparin
Figure Low Molecular Weight Heparin Industrial Chain Analysis
Table Raw Materials Sources of Low Molecular Weight Heparin Major Players/Suppliers in 2016
Table Major Buyers of Low Molecular Weight Heparin
Table Distributors/Traders List
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Low Molecular Weight Heparin Price (USD/MT) Trend Forecast (2017-2022)
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Type in 2022
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Application in 2022
Table United States Low Molecular Weight Heparin Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low Molecular Weight Heparin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

captcha
Can't read the image? click here to refresh
* mark fields are compulsory